Alsina-Fernandez; Jorge
Patent Applications and Registrations
Patent applications and USPTO patent grants for Alsina-Fernandez; Jorge.The latest application filed is for "gipr-agonist compounds".
Company Profile
6.16.30
- Alsina-Fernandez; Jorge - Indianapolis IN
Patent Activity
| Patent | Date |
|---|---|
| Glucagon Analog Agonists And Methods Of Using The Same App 20220125885 - Alsina-Fernandez; Jorge ; et al. | 2022-04-28 |
| Gipr-agonist Compounds App 20220127315 - ALSINA-FERNANDEZ; Jorge ; et al. | 2022-04-28 |
| GIPR-agonist compounds Grant 11,254,721 - Alsina-Fernandez , et al. February 22, 2 | 2022-02-22 |
| Gip/glp1 Co-agonist Compounds App 20220048967 - ABRAHAM; Milata Mary ; et al. | 2022-02-17 |
| GIP/GLP1 co-agonist compounds Grant 11,084,861 - Abraham , et al. August 10, 2 | 2021-08-10 |
| Incretin Analogs and Uses Thereof App 20210221865 - Alsina-Fernandez; Jorge ; et al. | 2021-07-22 |
| Gipr-agonist Compounds App 20210032299 - ALSINA-FERNANDEZ; Jorge ; et al. | 2021-02-04 |
| Fatty acid modified urocortin-2 analogs for the treatment of diabetes and chronic kidney disease Grant 10,894,817 - Alsina-Fernandez , et al. January 19, 2 | 2021-01-19 |
| Incretin Analogs and Uses Thereof App 20200331980 - Alsina-Fernandez; Jorge ; et al. | 2020-10-22 |
| Gip/glp1 Co-agonist Compounds App 20200024322 - Abraham; Milata Mary ; et al. | 2020-01-23 |
| Glucagon Receptor Agonists App 20180104312 - Alsina-Fernandez; Jorge ; et al. | 2018-04-19 |
| Glucagon receptor agonists Grant 9,884,093 - Alsina-Fernandez , et al. February 6, 2 | 2018-02-06 |
| Novel Fatty Acid Modified Urocortin-2 Analogs for the Treatment of Diabetes and Chronic Kidney Disease App 20180016318 - Alsina-Fernandez; Jorge ; et al. | 2018-01-18 |
| Glucagon receptor agonists Grant 9,764,004 - Alsina-Fernandez , et al. September 19, 2 | 2017-09-19 |
| Peptide compound for treatment of severe hypoglycemia Grant 9,695,225 - Alsina-Fernandez , et al. July 4, 2 | 2017-07-04 |
| Compound for treatment of severe hypoglycemia Grant 9,688,736 - Alsina-Fernandez , et al. June 27, 2 | 2017-06-27 |
| Glucagon Receptor Agonists App 20170114115 - Alsina-Fernandez; Jorge ; et al. | 2017-04-27 |
| Glucagon Receptor Agonists App 20170112904 - Alsina-Fernandez; Jorge ; et al. | 2017-04-27 |
| Novel Compound for Treatment of Severe Hypoglycemia App 20160311882 - Alsina-Fernandez; Jorge ; et al. | 2016-10-27 |
| Novel Compound for Treatment of Severe Hypoglycemia App 20160311883 - Alsina-Fernandez; Jorge ; et al. | 2016-10-27 |
| Novel Compound for Treatment of Severe Hypoglycemia App 20160311881 - Alsina-Fernandez; Jorge ; et al. | 2016-10-27 |
| GIP and GLP-1 co-agonist compounds Grant 9,474,780 - Bokvist , et al. October 25, 2 | 2016-10-25 |
| Gip And Glp-1 Co-agonist Compounds App 20160199438 - Bokvist; Bengt Krister ; et al. | 2016-07-14 |
| Peptides and methods for their preparation and use Grant 8,815,811 - Alsina-Fernandez , et al. August 26, 2 | 2014-08-26 |
| Homodimeric Proteins App 20140056893 - Coskun; Tamer ; et al. | 2014-02-27 |
| Oxyntomodulin peptide analogue Grant 8,415,296 - Alsina-Fernandez , et al. April 9, 2 | 2013-04-09 |
| Oxyntomodulin peptide analogue Grant 8,367,607 - Alsina-Fernandez , et al. February 5, 2 | 2013-02-05 |
| Novel Peptides And Methods For Their Preparation And Use App 20110237503 - ALSINA-FERNANDEZ; Jorge ; et al. | 2011-09-29 |
| Oxyntomodulin Peptide Analogue App 20110152182 - Alsina-Fernandez; Jorge ; et al. | 2011-06-23 |
| Oxyntomodulin Peptide Analogue App 20110152181 - ALSINA-FERNANDEZ; Jorge ; et al. | 2011-06-23 |
| Selective VPAC2 receptor peptide agonists Grant 7,897,573 - Bokvist , et al. March 1, 2 | 2011-03-01 |
| Selective Vpac2 Receptor Peptide Agonists App 20100048460 - Zhang; Lianshan ; et al. | 2010-02-25 |
| Selective Vpac2 Receptor Peptide Agonists App 20100009916 - BOKVIST; BENGT KRISTER ; et al. | 2010-01-14 |
| Selective VPAC2 receptor peptide agonists Grant 7,582,608 - Bokvist , et al. September 1, 2 | 2009-09-01 |
| Selective Vpac2 Receptor Peptide Agonists App 20090118167 - Bokvist; Bengt Krister ; et al. | 2009-05-07 |
| Selective Vpac2 Receptor Peptide Agonists App 20090082276 - Zhang; Lianshan ; et al. | 2009-03-26 |
| Selective Vpac2 Receptor Peptide Agonists App 20080318845 - Bokvist; Bengt Krister ; et al. | 2008-12-25 |
| Selective Vpac2 Receptor Peptide Agonists App 20080234198 - Bokvist; Bengt Krister ; et al. | 2008-09-25 |
| Selective Apac2 Receptor Peptide Agonists App 20080194482 - Alsina-Fernandez; Jorge ; et al. | 2008-08-14 |
| Selective Vpac2 Receptor Peptide Agonists App 20080146500 - Bokvist; Bengt Krister ; et al. | 2008-06-19 |
| Selective Vpac2 Receptor Peptide Agonists App 20080096811 - Bokvist; Bengt Krister ; et al. | 2008-04-24 |
| Selective Vpac2 Receptor Peptide Agonists App 20080085860 - Bokvist; Bengt Krister ; et al. | 2008-04-10 |
| Selective Vpac2 Receptor Reptide Agonists App 20080026996 - Bokvist; Bengt Krister ; et al. | 2008-01-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 